GUSKA
Turning viruses into anti-cancer nanoweapons
Improving the lives of cancer patients through synthetic RNA viral technologies
Guska uses certain viruses to design treatments that can specifically target cancer cells without harming healthy ones.
Team
Gonzalo Moratorio – Founder
Virologist (PostDoc training at the Virology Department of the Institut Pasteur Paris); PhD in Molecular and Cellular Biology (IP Montevideo and Udelar)
Pilar Moreno – Co-founder
PhD in Molecular and Cellular Biology; Biochemist (IP Montevideo and Udelar)
Fabián Aldunate - Researcher
Medical Doctor; MSc. in Molecular and Cellular Biology; Biochemist
Joaquín Hurtado – Researcher
MSc. in Molecular and Cellular Biology; Biochemist
Paula Perbolianachis – Researcher
MSc in Biological Sciences; Biologist
Juan Gandioli – Researcher
Biotechnology Engineer
Manuela Machado – Researcher
Biotechnology Engineer